Patents
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
11/1999
11/25/1999CA2327314A1 Soluble t cell receptor
11/18/1999WO1999041416A3 Compositions comprising viruses and methods for concentrating virus preparations
11/17/1999EP0957165A2 Optimizing cells for endogenous gene activation
11/16/1999CA2056402C Therapeutic agent
11/04/1999CA2327352A1 Novel serine protease capable of selective cleavage of insulin-like growth factor binding protein
10/1999
10/27/1999EP0951536A1 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
10/26/1999US5972896 Antiangiogenic peptides and methods for inhibiting angiogenesis
10/21/1999WO1999053086A1 Small molecule anticancer compounds and related production process
10/21/1999CA2325662A1 Regulable gene expression in gram-positive bacteria
10/20/1999EP0950109A1 Glyphosate resistant transgenic plants
10/20/1999CN1232469A RET ligand (RetL) for stimulating neural and renal growth
10/13/1999EP0948605A1 Truncated platelet-activating factor acetylhydrolase
10/13/1999EP0948349A1 Treatment of inner ear hair cells
10/12/1999US5965359 Mixing cells from biological sample with detectable labeled complementary dna probe, detecting the presence of the probe that hybridizes with messenger rna for human platelet-derived growth factor receptor gene
10/07/1999WO1999040182A3 CRYSTALLINE TNF-α-CONVERTING ENZYME AND USES THEREOF
10/06/1999EP0947583A2 DNA fragments activated in expression of melanoma inhibiting protein (MIA)
10/06/1999CN1230991A Hamster EF-1 'alpha' transcriptional regulatory DNA
09/1999
09/30/1999WO1999049067A1 Nucleic acid transfer vectors, compositions containing same and uses
09/30/1999WO1999049016A1 Process for continuous purification and concentration of leukocytes from blood
09/30/1999DE19913864A1 DNA fragments useful for increasing p53 activity in a cell and reducing susceptibility to UV-induced hyperproliferative diseases
09/30/1999CA2323831A1 Nucleic acid transfer vectors, compositions containing same and uses
09/28/1999US5958737 Single-chain β subunit dimers of the glycoprotein hormones and recombinant materials related thereto
09/28/1999US5958425 Viral vaccines
09/22/1999CN1229434A Method of attenuating viruses
09/16/1999WO1999046316A2 Enzyme inhibitors
09/16/1999WO1996012802A9 Vaccine and antitoxin for treatment and prevention of c. difficile disease
09/16/1999CA2323496A1 Enzyme inhibitors
09/16/1999CA2321677A1 Novel polypeptides and nucleic acids encoding the same which are useful for treating inner ear diseases
09/15/1999EP0941243A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use
09/08/1999EP0790981B1 Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors
09/01/1999CN1227606A Purified proteins, recombinant DNA sequences and processes for controlling the ripening of coffee plants
08/1999
08/19/1999WO1999041416A2 Compositions comprising viruses and methods for concentrating virus preparations
08/19/1999CA2723040A1 Compositions comprising viruses and methods for concentrating virus preparations
08/17/1999US5939598 Method of making transgenic mice lacking endogenous heavy chains
08/17/1999US5939289 DNA compounds comprising sequences encoding mannuronan C-5-epimerase
08/12/1999WO1999040182A2 CRYSTALLINE TNF-α-CONVERTING ENZYME AND USES THEREOF
08/12/1999CA2319040A1 Crystalline tnf-.alpha.-converting enzyme and uses thereof
08/10/1999US5935795 Glial cell line-derived neurotrophic factor antibody
08/05/1999WO1999038973A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
08/05/1999WO1999025843A3 Human checkpoint kinase, hcds1, compositions and methods
08/05/1999CA2319117A1 Compounds for therapy and diagnosis of lung cancer and methods for their use
08/04/1999EP0932681A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
07/1999
07/27/1999US5929212 CD3 specific recombinant antibody
07/27/1999CA2167520C Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
07/27/1999CA2071989C Endogenous gene expression modification with regulatory element
07/22/1999WO1999024553A8 X-ray crystal comprising hiv-1 gp120
07/21/1999CN1223690A Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization
07/20/1999US5925361 Ornithobacterium rhinotracheale vaccines
07/20/1999US5925347 Viral vector vaccines comprising nucleic acids encoding eimeria proteins for poultry vaccination against coccidiosis
07/15/1999WO1999023232B1 Glyphosate resistant transgenic plants
07/14/1999CN1222917A Novel protein and process for producing the same
07/06/1999CA1340628C T7 dna polymerase
07/01/1999WO1999020747A3 HUMAN CHECKPOINT KINASE, hCDS1, COMPOSITIONS AND METHODS
06/1999
06/23/1999CN1220270A Improved process for stabilizing proteins
06/16/1999EP0922092A1 Method of attenuating viruses
06/09/1999EP0920498A1 HAMSTER EF-1$g(a) TRANSCRIPTIONAL REGULATORY DNA
06/09/1999EP0629242B1 Method for enhancing plant precocity and/or reducing the stored nitrate content of a plant
06/03/1999WO1999027100A1 Fibroblast growth factor-19
06/02/1999EP0919619A2 Optimizing cells for endogenous gene activation
06/02/1999EP0918869A1 Purified proteins, recombinant dna sequences and processes for controlling the ripening of coffee plants
06/01/1999US5908839 Administering mixture of tyrosine kinase inhibitor and amino sterol
05/1999
05/27/1999WO1999025843A2 Human checkpoint kinase, hcds1, compositions and methods
05/27/1999CA2306492A1 Human checkpoint kinase, hcds1, compositions and methods
05/26/1999EP0917879A2 Procédé amélioré pour la stabilisation des protéines
05/20/1999WO1999024553A2 X-ray crystal comprising hiv-1 gp120
05/19/1999EP0434747B1 RECOMBINANT VACCINES BASED ON THE gB-PROTEIN OF MAREK'S DISEASE VIRUS
05/18/1999CA1340548C Method for producing native hiv gp160
05/14/1999WO1999023232A1 Glyphosate resistant transgenic plants
05/14/1999CA2279258A1 Glyphosate resistant transgenic plants
05/12/1999EP0914339A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH
05/06/1999WO1999021998A1 Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3
05/06/1999EP0913156A1 Methods for treating hypercoagulable states or acquired protein C deficiency
05/06/1999CA2306183A1 Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3
05/05/1999CN1216063A IL-6 mutein
04/1999
04/29/1999WO1999020747A2 HUMAN CHECKPOINT KINASE, hCDS1, COMPOSITIONS AND METHODS
04/29/1999WO1999020293A1 Methods for treating hypercoagulable states or acquired protein c deficiency
04/29/1999CA2308013A1 Human checkpoint kinase, hcds1, compositions and methods
04/29/1999CA2306983A1 Methods for treating hypercoagulable states or acquired protein c deficiency
04/28/1999EP0911342A1 Novel protein and process for producing the same
04/28/1999EP0910571A2 Novel antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis
04/28/1999EP0456766B1 TYPE oc PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE
04/27/1999CA1340512C Expression of factor vii and ix activities in mammalian cells
04/22/1999WO1999019498A1 Transgenic lemnaceae
04/22/1999WO1999019497A1 Transgenic lemnaceae
04/22/1999WO1998045328A3 Compositions and methods for the treatment and diagnosis of breast cancer
04/20/1999US5895654 Streptococcus equi vaccine
04/15/1999WO1999018223A1 A process for obtaining transgenic leguminous plants (leguminosae) containing exogenous dna
04/14/1999EP0907737A1 Il-6 mutein
04/14/1999CN1214083A Mixture of recominant vaccinia vectors as polyenv vaccines for HIV
04/01/1999CA2302806A1 Macrophage derived chemokine (mdc), mdc analogs, mdc inhibitor substances, and uses thereof
03/1999
03/30/1999US5888809 Hamster EF-1α transcriptional regulatory DNA
03/30/1999US5888808 Bacterial polypeptide expression employing tryptophan promoter-operator
03/16/1999US5882907 Design of new ribozymes capable of self-catalyzed trans-splicing which are based upon the catalytic core of a group i intron are described
03/16/1999US5882655 Serpulina hyodysenteriae vaccine comprising a hygene mutant
03/10/1999CN1210558A Recombinant phages
03/10/1999CN1210150A Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
03/09/1999US5880113 Antiproliferative agents, cell differentiation inducers
03/09/1999CA2080355C Isolated viral protein cytokine antagonists
03/04/1999WO1999010497A1 Novel mutants of gram negative mucosal bacteria and application thereof in vaccines
03/02/1999US5876988 Selection marker gene free recombinant strains: method for obtaining them and the use of these strains
1 ... 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100